Based on results from 364 patients with liver cancer, poorer prognoses in terms of OS and DFS (P < 0.05) were associated with lower mRNA expression levels for DOK5 (Figures 3(c) and 3(d)). This evidence concerns the gene DOK5 and liver cancer.